nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CYP2E1—Dacarbazine—sarcoma	0.0815	0.127	CbGbCtD
Pimozide—CYP2E1—Mitoxantrone—sarcoma	0.0632	0.0983	CbGbCtD
Pimozide—CYP1A2—Dacarbazine—sarcoma	0.0471	0.0732	CbGbCtD
Pimozide—CYP3A7—Vincristine—sarcoma	0.0451	0.07	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0451	0.07	CbGbCtD
Pimozide—CYP3A4—Thiotepa—sarcoma	0.0445	0.0692	CbGbCtD
Pimozide—CYP2E1—Etoposide—sarcoma	0.0399	0.062	CbGbCtD
Pimozide—ABCB1—Dactinomycin—sarcoma	0.0357	0.0555	CbGbCtD
Pimozide—CYP3A5—Vincristine—sarcoma	0.0338	0.0525	CbGbCtD
Pimozide—ABCB1—Mitoxantrone—sarcoma	0.032	0.0497	CbGbCtD
Pimozide—CYP3A5—Etoposide—sarcoma	0.031	0.0481	CbGbCtD
Pimozide—CYP1A2—Etoposide—sarcoma	0.0231	0.0358	CbGbCtD
Pimozide—ABCB1—Vincristine—sarcoma	0.022	0.0342	CbGbCtD
Pimozide—ABCB1—Etoposide—sarcoma	0.0202	0.0313	CbGbCtD
Pimozide—CYP3A4—Mitoxantrone—sarcoma	0.0192	0.0298	CbGbCtD
Pimozide—ABCB1—Doxorubicin—sarcoma	0.0137	0.0214	CbGbCtD
Pimozide—CYP3A4—Vincristine—sarcoma	0.0132	0.0205	CbGbCtD
Pimozide—CYP2D6—Doxorubicin—sarcoma	0.013	0.0201	CbGbCtD
Pimozide—CYP3A4—Etoposide—sarcoma	0.0121	0.0188	CbGbCtD
Pimozide—CYP3A4—Doxorubicin—sarcoma	0.00824	0.0128	CbGbCtD
Pimozide—HTR2A—pulmonary artery—sarcoma	0.00285	0.0488	CbGeAlD
Pimozide—HTR2A—hindlimb—sarcoma	0.00172	0.0295	CbGeAlD
Pimozide—CALM3—mammary gland—sarcoma	0.00151	0.0259	CbGeAlD
Pimozide—HTR2A—appendage—sarcoma	0.00148	0.0253	CbGeAlD
Pimozide—CALM2—endothelium—sarcoma	0.00147	0.0252	CbGeAlD
Pimozide—CALM1—endothelium—sarcoma	0.00147	0.0251	CbGeAlD
Pimozide—CALM1—mammary gland—sarcoma	0.00118	0.0202	CbGeAlD
Pimozide—CALM3—myometrium—sarcoma	0.00107	0.0184	CbGeAlD
Pimozide—OPRM1—hematopoietic system—sarcoma	0.000997	0.0171	CbGeAlD
Pimozide—CALM3—seminal vesicle—sarcoma	0.000969	0.0166	CbGeAlD
Pimozide—HTR2A—endothelium—sarcoma	0.000893	0.0153	CbGeAlD
Pimozide—CALM2—myometrium—sarcoma	0.000842	0.0144	CbGeAlD
Pimozide—CALM1—myometrium—sarcoma	0.000839	0.0144	CbGeAlD
Pimozide—CALM3—smooth muscle tissue—sarcoma	0.000811	0.0139	CbGeAlD
Pimozide—CALM2—embryo—sarcoma	0.00081	0.0139	CbGeAlD
Pimozide—CALM1—embryo—sarcoma	0.000807	0.0138	CbGeAlD
Pimozide—CYP3A7—liver—sarcoma	0.000796	0.0136	CbGeAlD
Pimozide—KCNH2—myometrium—sarcoma	0.000763	0.0131	CbGeAlD
Pimozide—CALM2—seminal vesicle—sarcoma	0.000761	0.013	CbGeAlD
Pimozide—HTR1A—hematopoietic system—sarcoma	0.000736	0.0126	CbGeAlD
Pimozide—CALM2—hematopoietic system—sarcoma	0.000723	0.0124	CbGeAlD
Pimozide—CALM1—hematopoietic system—sarcoma	0.00072	0.0123	CbGeAlD
Pimozide—CALM3—cardiac atrium—sarcoma	0.000699	0.012	CbGeAlD
Pimozide—CALM2—connective tissue—sarcoma	0.000696	0.0119	CbGeAlD
Pimozide—CALM3—uterus—sarcoma	0.000696	0.0119	CbGeAlD
Pimozide—CALM1—connective tissue—sarcoma	0.000693	0.0119	CbGeAlD
Pimozide—KCNH2—seminal vesicle—sarcoma	0.000689	0.0118	CbGeAlD
Pimozide—CYP2C19—hematopoietic system—sarcoma	0.000687	0.0118	CbGeAlD
Pimozide—CYP3A7-CYP3A51P—liver—sarcoma	0.000677	0.0116	CbGeAlD
Pimozide—KCNH2—hematopoietic system—sarcoma	0.000655	0.0112	CbGeAlD
Pimozide—CALM2—smooth muscle tissue—sarcoma	0.000637	0.0109	CbGeAlD
Pimozide—CALM1—smooth muscle tissue—sarcoma	0.000634	0.0109	CbGeAlD
Pimozide—CALM2—skin of body—sarcoma	0.000629	0.0108	CbGeAlD
Pimozide—CALM1—skin of body—sarcoma	0.000626	0.0107	CbGeAlD
Pimozide—Amenorrhoea—Epirubicin—sarcoma	0.000616	0.00526	CcSEcCtD
Pimozide—HRH1—myometrium—sarcoma	0.000612	0.0105	CbGeAlD
Pimozide—CALM3—tendon—sarcoma	0.00061	0.0104	CbGeAlD
Pimozide—Agranulocytosis—Mitoxantrone—sarcoma	0.000606	0.00517	CcSEcCtD
Pimozide—Dysphagia—Etoposide—sarcoma	0.000605	0.00517	CcSEcCtD
Pimozide—Blood disorder—Doxorubicin—sarcoma	0.000599	0.00512	CcSEcCtD
Pimozide—Mental disorder—Thiotepa—sarcoma	0.000591	0.00505	CcSEcCtD
Pimozide—CALM3—bone marrow—sarcoma	0.00059	0.0101	CbGeAlD
Pimozide—Connective tissue disorder—Vincristine—sarcoma	0.000588	0.00502	CcSEcCtD
Pimozide—Nocturia—Epirubicin—sarcoma	0.000583	0.00498	CcSEcCtD
Pimozide—Dyskinesia—Epirubicin—sarcoma	0.000576	0.00492	CcSEcCtD
Pimozide—Pancytopenia—Etoposide—sarcoma	0.000575	0.00491	CcSEcCtD
Pimozide—Amenorrhoea—Doxorubicin—sarcoma	0.00057	0.00487	CcSEcCtD
Pimozide—CYP1A2—hematopoietic system—sarcoma	0.000561	0.00961	CbGeAlD
Pimozide—Cardiac disorder—Vincristine—sarcoma	0.000555	0.00474	CcSEcCtD
Pimozide—Vision blurred—Thiotepa—sarcoma	0.000554	0.00473	CcSEcCtD
Pimozide—CALM2—cardiac atrium—sarcoma	0.000549	0.00941	CbGeAlD
Pimozide—CALM1—cardiac atrium—sarcoma	0.000547	0.00936	CbGeAlD
Pimozide—CALM2—uterus—sarcoma	0.000546	0.00936	CbGeAlD
Pimozide—OPRM1—testis—sarcoma	0.000546	0.00935	CbGeAlD
Pimozide—CALM1—uterus—sarcoma	0.000544	0.00931	CbGeAlD
Pimozide—Anaemia—Thiotepa—sarcoma	0.000543	0.00464	CcSEcCtD
Pimozide—CYP3A5—hematopoietic system—sarcoma	0.000541	0.00927	CbGeAlD
Pimozide—Ventricular tachycardia—Epirubicin—sarcoma	0.000541	0.00462	CcSEcCtD
Pimozide—Agitation—Thiotepa—sarcoma	0.00054	0.00461	CcSEcCtD
Pimozide—Nocturia—Doxorubicin—sarcoma	0.00054	0.00461	CcSEcCtD
Pimozide—Anaemia—Dactinomycin—sarcoma	0.000539	0.0046	CcSEcCtD
Pimozide—Abnormal dreams—Epirubicin—sarcoma	0.000535	0.00457	CcSEcCtD
Pimozide—Dyskinesia—Doxorubicin—sarcoma	0.000533	0.00455	CcSEcCtD
Pimozide—Eructation—Epirubicin—sarcoma	0.000531	0.00454	CcSEcCtD
Pimozide—CYP2E1—seminal vesicle—sarcoma	0.000531	0.00909	CbGeAlD
Pimozide—Leukopenia—Thiotepa—sarcoma	0.000526	0.00449	CcSEcCtD
Pimozide—Salivary hypersecretion—Epirubicin—sarcoma	0.000525	0.00449	CcSEcCtD
Pimozide—HRH1—hematopoietic system—sarcoma	0.000525	0.00899	CbGeAlD
Pimozide—Mental disorder—Vincristine—sarcoma	0.000524	0.00448	CcSEcCtD
Pimozide—Leukopenia—Dactinomycin—sarcoma	0.000522	0.00446	CcSEcCtD
Pimozide—CALM2—lymphoid tissue—sarcoma	0.000509	0.00872	CbGeAlD
Pimozide—Convulsion—Thiotepa—sarcoma	0.000509	0.00435	CcSEcCtD
Pimozide—Aplastic anaemia—Epirubicin—sarcoma	0.000508	0.00434	CcSEcCtD
Pimozide—Hypertension—Thiotepa—sarcoma	0.000507	0.00433	CcSEcCtD
Pimozide—CALM1—lymphoid tissue—sarcoma	0.000507	0.00868	CbGeAlD
Pimozide—HRH1—connective tissue—sarcoma	0.000506	0.00866	CbGeAlD
Pimozide—CALM3—testis—sarcoma	0.000505	0.00864	CbGeAlD
Pimozide—CYP2E1—hematopoietic system—sarcoma	0.000505	0.00864	CbGeAlD
Pimozide—Agranulocytosis—Etoposide—sarcoma	0.000504	0.0043	CcSEcCtD
Pimozide—Ventricular tachycardia—Doxorubicin—sarcoma	0.000501	0.00428	CcSEcCtD
Pimozide—Myalgia—Thiotepa—sarcoma	0.0005	0.00427	CcSEcCtD
Pimozide—KCNH2—cardiac atrium—sarcoma	0.000498	0.00852	CbGeAlD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000497	0.00424	CcSEcCtD
Pimozide—Myalgia—Dactinomycin—sarcoma	0.000496	0.00424	CcSEcCtD
Pimozide—KCNH2—uterus—sarcoma	0.000495	0.00848	CbGeAlD
Pimozide—Abnormal dreams—Doxorubicin—sarcoma	0.000495	0.00423	CcSEcCtD
Pimozide—Eructation—Doxorubicin—sarcoma	0.000492	0.0042	CcSEcCtD
Pimozide—HTR2A—embryo—sarcoma	0.000491	0.00841	CbGeAlD
Pimozide—Salivary hypersecretion—Doxorubicin—sarcoma	0.000486	0.00415	CcSEcCtD
Pimozide—Anaemia—Vincristine—sarcoma	0.000481	0.00411	CcSEcCtD
Pimozide—CALM2—tendon—sarcoma	0.000479	0.0082	CbGeAlD
Pimozide—Agitation—Vincristine—sarcoma	0.000479	0.00409	CcSEcCtD
Pimozide—Vision blurred—Mitoxantrone—sarcoma	0.000478	0.00408	CcSEcCtD
Pimozide—CALM3—liver—sarcoma	0.000477	0.00817	CbGeAlD
Pimozide—CALM1—tendon—sarcoma	0.000477	0.00816	CbGeAlD
Pimozide—Nervous system disorder—Thiotepa—sarcoma	0.00047	0.00402	CcSEcCtD
Pimozide—Aplastic anaemia—Doxorubicin—sarcoma	0.00047	0.00401	CcSEcCtD
Pimozide—Anaemia—Mitoxantrone—sarcoma	0.000469	0.004	CcSEcCtD
Pimozide—Tachycardia—Thiotepa—sarcoma	0.000468	0.004	CcSEcCtD
Pimozide—Leukopenia—Vincristine—sarcoma	0.000466	0.00398	CcSEcCtD
Pimozide—Skin disorder—Thiotepa—sarcoma	0.000466	0.00398	CcSEcCtD
Pimozide—CALM2—bone marrow—sarcoma	0.000464	0.00794	CbGeAlD
Pimozide—HRH1—smooth muscle tissue—sarcoma	0.000463	0.00792	CbGeAlD
Pimozide—CALM1—bone marrow—sarcoma	0.000462	0.0079	CbGeAlD
Pimozide—Anorexia—Thiotepa—sarcoma	0.000457	0.0039	CcSEcCtD
Pimozide—Leukopenia—Mitoxantrone—sarcoma	0.000454	0.00388	CcSEcCtD
Pimozide—Anorexia—Dactinomycin—sarcoma	0.000453	0.00387	CcSEcCtD
Pimozide—Eye disorder—Etoposide—sarcoma	0.000453	0.00387	CcSEcCtD
Pimozide—Convulsion—Vincristine—sarcoma	0.000451	0.00385	CcSEcCtD
Pimozide—Cardiac disorder—Etoposide—sarcoma	0.00045	0.00384	CcSEcCtD
Pimozide—Hypertension—Vincristine—sarcoma	0.00045	0.00384	CcSEcCtD
Pimozide—Myalgia—Vincristine—sarcoma	0.000443	0.00379	CcSEcCtD
Pimozide—Convulsion—Mitoxantrone—sarcoma	0.000439	0.00375	CcSEcCtD
Pimozide—HTR2A—hematopoietic system—sarcoma	0.000439	0.00751	CbGeAlD
Pimozide—Hypertension—Mitoxantrone—sarcoma	0.000438	0.00374	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000437	0.00373	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000433	0.0037	CcSEcCtD
Pimozide—Myalgia—Mitoxantrone—sarcoma	0.000432	0.00369	CcSEcCtD
Pimozide—Chest pain—Mitoxantrone—sarcoma	0.000432	0.00369	CcSEcCtD
Pimozide—Somnolence—Thiotepa—sarcoma	0.000426	0.00364	CcSEcCtD
Pimozide—HTR2A—connective tissue—sarcoma	0.000422	0.00723	CbGeAlD
Pimozide—KCNH2—bone marrow—sarcoma	0.00042	0.00719	CbGeAlD
Pimozide—Increased appetite—Epirubicin—sarcoma	0.000418	0.00357	CcSEcCtD
Pimozide—Nervous system disorder—Vincristine—sarcoma	0.000417	0.00356	CcSEcCtD
Pimozide—Decreased appetite—Thiotepa—sarcoma	0.000417	0.00356	CcSEcCtD
Pimozide—Gastrointestinal disorder—Thiotepa—sarcoma	0.000414	0.00353	CcSEcCtD
Pimozide—Decreased appetite—Dactinomycin—sarcoma	0.000414	0.00353	CcSEcCtD
Pimozide—Hyperhidrosis—Vincristine—sarcoma	0.000411	0.00351	CcSEcCtD
Pimozide—Constipation—Thiotepa—sarcoma	0.00041	0.0035	CcSEcCtD
Pimozide—Shock—Mitoxantrone—sarcoma	0.000407	0.00348	CcSEcCtD
Pimozide—CYP3A4—hematopoietic system—sarcoma	0.000406	0.00695	CbGeAlD
Pimozide—Muscle spasms—Etoposide—sarcoma	0.000406	0.00346	CcSEcCtD
Pimozide—Anorexia—Vincristine—sarcoma	0.000405	0.00346	CcSEcCtD
Pimozide—Tachycardia—Mitoxantrone—sarcoma	0.000404	0.00345	CcSEcCtD
Pimozide—Skin disorder—Mitoxantrone—sarcoma	0.000402	0.00343	CcSEcCtD
Pimozide—Hyperhidrosis—Mitoxantrone—sarcoma	0.0004	0.00342	CcSEcCtD
Pimozide—CYP2D6—hematopoietic system—sarcoma	0.0004	0.00684	CbGeAlD
Pimozide—Hypotension—Vincristine—sarcoma	0.000397	0.00339	CcSEcCtD
Pimozide—CALM2—testis—sarcoma	0.000396	0.00679	CbGeAlD
Pimozide—Anorexia—Mitoxantrone—sarcoma	0.000395	0.00337	CcSEcCtD
Pimozide—CALM1—testis—sarcoma	0.000395	0.00676	CbGeAlD
Pimozide—Hyponatraemia—Epirubicin—sarcoma	0.000394	0.00337	CcSEcCtD
Pimozide—Anaemia—Etoposide—sarcoma	0.00039	0.00333	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Vincristine—sarcoma	0.000387	0.00331	CcSEcCtD
Pimozide—Hypotension—Mitoxantrone—sarcoma	0.000387	0.0033	CcSEcCtD
Pimozide—Increased appetite—Doxorubicin—sarcoma	0.000387	0.0033	CcSEcCtD
Pimozide—HTR2A—smooth muscle tissue—sarcoma	0.000386	0.00662	CbGeAlD
Pimozide—Insomnia—Vincristine—sarcoma	0.000384	0.00328	CcSEcCtD
Pimozide—Urticaria—Thiotepa—sarcoma	0.000381	0.00325	CcSEcCtD
Pimozide—Leukopenia—Etoposide—sarcoma	0.000378	0.00323	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000377	0.00322	CcSEcCtD
Pimozide—CALM2—liver—sarcoma	0.000375	0.00642	CbGeAlD
Pimozide—CALM1—liver—sarcoma	0.000373	0.00639	CbGeAlD
Pimozide—Loss of consciousness—Etoposide—sarcoma	0.000371	0.00317	CcSEcCtD
Pimozide—Decreased appetite—Vincristine—sarcoma	0.000369	0.00316	CcSEcCtD
Pimozide—Somnolence—Mitoxantrone—sarcoma	0.000368	0.00314	CcSEcCtD
Pimozide—Gastrointestinal disorder—Vincristine—sarcoma	0.000367	0.00313	CcSEcCtD
Pimozide—CALM3—lymph node—sarcoma	0.000366	0.00627	CbGeAlD
Pimozide—Convulsion—Etoposide—sarcoma	0.000366	0.00312	CcSEcCtD
Pimozide—Hyponatraemia—Doxorubicin—sarcoma	0.000365	0.00312	CcSEcCtD
Pimozide—DRD2—testis—sarcoma	0.000364	0.00624	CbGeAlD
Pimozide—Hypertension—Etoposide—sarcoma	0.000364	0.00311	CcSEcCtD
Pimozide—Constipation—Vincristine—sarcoma	0.000363	0.0031	CcSEcCtD
Pimozide—Decreased appetite—Mitoxantrone—sarcoma	0.00036	0.00307	CcSEcCtD
Pimozide—Chest pain—Etoposide—sarcoma	0.000359	0.00307	CcSEcCtD
Pimozide—KCNH2—testis—sarcoma	0.000359	0.00615	CbGeAlD
Pimozide—Orthostatic hypotension—Epirubicin—sarcoma	0.000359	0.00306	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000357	0.00305	CcSEcCtD
Pimozide—CYP2C19—liver—sarcoma	0.000356	0.00609	CbGeAlD
Pimozide—CYP2E1—lymphoid tissue—sarcoma	0.000355	0.00608	CbGeAlD
Pimozide—Breast disorder—Epirubicin—sarcoma	0.000355	0.00303	CcSEcCtD
Pimozide—Constipation—Mitoxantrone—sarcoma	0.000354	0.00302	CcSEcCtD
Pimozide—HRH1—tendon—sarcoma	0.000348	0.00595	CbGeAlD
Pimozide—Asthenia—Thiotepa—sarcoma	0.000344	0.00294	CcSEcCtD
Pimozide—Asthenia—Dactinomycin—sarcoma	0.000341	0.00292	CcSEcCtD
Pimozide—Dysphagia—Epirubicin—sarcoma	0.000339	0.0029	CcSEcCtD
Pimozide—Pruritus—Thiotepa—sarcoma	0.000339	0.0029	CcSEcCtD
Pimozide—Tachycardia—Etoposide—sarcoma	0.000336	0.00287	CcSEcCtD
Pimozide—Eosinophilia—Epirubicin—sarcoma	0.000336	0.00287	CcSEcCtD
Pimozide—ABCB1—myometrium—sarcoma	0.000335	0.00573	CbGeAlD
Pimozide—Skin disorder—Etoposide—sarcoma	0.000334	0.00286	CcSEcCtD
Pimozide—CYP2E1—tendon—sarcoma	0.000334	0.00572	CbGeAlD
Pimozide—Hyperhidrosis—Etoposide—sarcoma	0.000333	0.00284	CcSEcCtD
Pimozide—Orthostatic hypotension—Doxorubicin—sarcoma	0.000332	0.00283	CcSEcCtD
Pimozide—Urticaria—Mitoxantrone—sarcoma	0.000329	0.00281	CcSEcCtD
Pimozide—Breast disorder—Doxorubicin—sarcoma	0.000328	0.0028	CcSEcCtD
Pimozide—Anorexia—Etoposide—sarcoma	0.000328	0.0028	CcSEcCtD
Pimozide—Diarrhoea—Thiotepa—sarcoma	0.000328	0.0028	CcSEcCtD
Pimozide—Diarrhoea—Dactinomycin—sarcoma	0.000326	0.00278	CcSEcCtD
Pimozide—Pancytopenia—Epirubicin—sarcoma	0.000322	0.00275	CcSEcCtD
Pimozide—ABCB1—embryo—sarcoma	0.000322	0.00551	CbGeAlD
Pimozide—Hypotension—Etoposide—sarcoma	0.000322	0.00275	CcSEcCtD
Pimozide—Dizziness—Thiotepa—sarcoma	0.000317	0.00271	CcSEcCtD
Pimozide—Dysphagia—Doxorubicin—sarcoma	0.000314	0.00268	CcSEcCtD
Pimozide—Pollakiuria—Epirubicin—sarcoma	0.000314	0.00268	CcSEcCtD
Pimozide—Eosinophilia—Doxorubicin—sarcoma	0.000311	0.00266	CcSEcCtD
Pimozide—Weight increased—Epirubicin—sarcoma	0.000309	0.00264	CcSEcCtD
Pimozide—Weight decreased—Epirubicin—sarcoma	0.000307	0.00262	CcSEcCtD
Pimozide—Somnolence—Etoposide—sarcoma	0.000306	0.00261	CcSEcCtD
Pimozide—Asthenia—Vincristine—sarcoma	0.000305	0.0026	CcSEcCtD
Pimozide—Vomiting—Thiotepa—sarcoma	0.000305	0.0026	CcSEcCtD
Pimozide—Drowsiness—Epirubicin—sarcoma	0.000303	0.00258	CcSEcCtD
Pimozide—Vomiting—Dactinomycin—sarcoma	0.000302	0.00258	CcSEcCtD
Pimozide—ABCB1—seminal vesicle—sarcoma	0.000302	0.00518	CbGeAlD
Pimozide—Rash—Thiotepa—sarcoma	0.000302	0.00258	CcSEcCtD
Pimozide—Dermatitis—Thiotepa—sarcoma	0.000302	0.00258	CcSEcCtD
Pimozide—Headache—Thiotepa—sarcoma	0.0003	0.00256	CcSEcCtD
Pimozide—Rash—Dactinomycin—sarcoma	0.0003	0.00256	CcSEcCtD
Pimozide—Decreased appetite—Etoposide—sarcoma	0.000299	0.00256	CcSEcCtD
Pimozide—Pancytopenia—Doxorubicin—sarcoma	0.000298	0.00255	CcSEcCtD
Pimozide—Gastrointestinal disorder—Etoposide—sarcoma	0.000297	0.00254	CcSEcCtD
Pimozide—Asthenia—Mitoxantrone—sarcoma	0.000297	0.00254	CcSEcCtD
Pimozide—Constipation—Etoposide—sarcoma	0.000294	0.00251	CcSEcCtD
Pimozide—Diarrhoea—Vincristine—sarcoma	0.000291	0.00248	CcSEcCtD
Pimozide—CYP1A2—liver—sarcoma	0.000291	0.00498	CbGeAlD
Pimozide—HTR2A—tendon—sarcoma	0.00029	0.00497	CbGeAlD
Pimozide—Sweating—Epirubicin—sarcoma	0.00029	0.00248	CcSEcCtD
Pimozide—Pollakiuria—Doxorubicin—sarcoma	0.00029	0.00248	CcSEcCtD
Pimozide—HRH1—testis—sarcoma	0.000288	0.00493	CbGeAlD
Pimozide—ABCB1—hematopoietic system—sarcoma	0.000287	0.00492	CbGeAlD
Pimozide—CALM2—lymph node—sarcoma	0.000287	0.00492	CbGeAlD
Pimozide—CALM1—lymph node—sarcoma	0.000286	0.0049	CbGeAlD
Pimozide—Weight increased—Doxorubicin—sarcoma	0.000286	0.00244	CcSEcCtD
Pimozide—Nausea—Thiotepa—sarcoma	0.000285	0.00243	CcSEcCtD
Pimozide—Weight decreased—Doxorubicin—sarcoma	0.000284	0.00243	CcSEcCtD
Pimozide—Diarrhoea—Mitoxantrone—sarcoma	0.000283	0.00242	CcSEcCtD
Pimozide—Nausea—Dactinomycin—sarcoma	0.000283	0.00241	CcSEcCtD
Pimozide—Agranulocytosis—Epirubicin—sarcoma	0.000282	0.00241	CcSEcCtD
Pimozide—Dizziness—Vincristine—sarcoma	0.000281	0.0024	CcSEcCtD
Pimozide—CYP3A5—liver—sarcoma	0.00028	0.0048	CbGeAlD
Pimozide—Drowsiness—Doxorubicin—sarcoma	0.00028	0.00239	CcSEcCtD
Pimozide—CYP2E1—testis—sarcoma	0.000277	0.00474	CbGeAlD
Pimozide—Urticaria—Etoposide—sarcoma	0.000274	0.00234	CcSEcCtD
Pimozide—Vomiting—Vincristine—sarcoma	0.00027	0.00231	CcSEcCtD
Pimozide—Sweating—Doxorubicin—sarcoma	0.000268	0.00229	CcSEcCtD
Pimozide—Rash—Vincristine—sarcoma	0.000268	0.00229	CcSEcCtD
Pimozide—Dermatitis—Vincristine—sarcoma	0.000268	0.00229	CcSEcCtD
Pimozide—Connective tissue disorder—Epirubicin—sarcoma	0.000267	0.00228	CcSEcCtD
Pimozide—Headache—Vincristine—sarcoma	0.000266	0.00227	CcSEcCtD
Pimozide—Vomiting—Mitoxantrone—sarcoma	0.000263	0.00225	CcSEcCtD
Pimozide—Visual impairment—Epirubicin—sarcoma	0.000262	0.00224	CcSEcCtD
Pimozide—CYP2E1—liver—sarcoma	0.000261	0.00448	CbGeAlD
Pimozide—Agranulocytosis—Doxorubicin—sarcoma	0.000261	0.00223	CcSEcCtD
Pimozide—Rash—Mitoxantrone—sarcoma	0.000261	0.00223	CcSEcCtD
Pimozide—Dermatitis—Mitoxantrone—sarcoma	0.000261	0.00223	CcSEcCtD
Pimozide—KCNH2—lymph node—sarcoma	0.00026	0.00446	CbGeAlD
Pimozide—Headache—Mitoxantrone—sarcoma	0.000259	0.00222	CcSEcCtD
Pimozide—Eye disorder—Epirubicin—sarcoma	0.000254	0.00217	CcSEcCtD
Pimozide—Nausea—Vincristine—sarcoma	0.000252	0.00216	CcSEcCtD
Pimozide—Cardiac disorder—Epirubicin—sarcoma	0.000252	0.00215	CcSEcCtD
Pimozide—Asthenia—Etoposide—sarcoma	0.000247	0.00211	CcSEcCtD
Pimozide—Connective tissue disorder—Doxorubicin—sarcoma	0.000247	0.00211	CcSEcCtD
Pimozide—Nausea—Mitoxantrone—sarcoma	0.000246	0.0021	CcSEcCtD
Pimozide—Pruritus—Etoposide—sarcoma	0.000244	0.00208	CcSEcCtD
Pimozide—Visual impairment—Doxorubicin—sarcoma	0.000242	0.00207	CcSEcCtD
Pimozide—HTR2A—testis—sarcoma	0.00024	0.00412	CbGeAlD
Pimozide—Mental disorder—Epirubicin—sarcoma	0.000238	0.00203	CcSEcCtD
Pimozide—Diarrhoea—Etoposide—sarcoma	0.000236	0.00201	CcSEcCtD
Pimozide—Eye disorder—Doxorubicin—sarcoma	0.000235	0.00201	CcSEcCtD
Pimozide—Cardiac disorder—Doxorubicin—sarcoma	0.000233	0.00199	CcSEcCtD
Pimozide—Dizziness—Etoposide—sarcoma	0.000228	0.00194	CcSEcCtD
Pimozide—Muscle spasms—Epirubicin—sarcoma	0.000227	0.00194	CcSEcCtD
Pimozide—HTR2A—liver—sarcoma	0.000227	0.00389	CbGeAlD
Pimozide—Vision blurred—Epirubicin—sarcoma	0.000223	0.0019	CcSEcCtD
Pimozide—Mental disorder—Doxorubicin—sarcoma	0.00022	0.00188	CcSEcCtD
Pimozide—CYP2D6—testis—sarcoma	0.000219	0.00375	CbGeAlD
Pimozide—Vomiting—Etoposide—sarcoma	0.000219	0.00187	CcSEcCtD
Pimozide—Anaemia—Epirubicin—sarcoma	0.000219	0.00187	CcSEcCtD
Pimozide—Agitation—Epirubicin—sarcoma	0.000217	0.00186	CcSEcCtD
Pimozide—ABCB1—uterus—sarcoma	0.000217	0.00372	CbGeAlD
Pimozide—Rash—Etoposide—sarcoma	0.000217	0.00185	CcSEcCtD
Pimozide—Dermatitis—Etoposide—sarcoma	0.000217	0.00185	CcSEcCtD
Pimozide—Headache—Etoposide—sarcoma	0.000216	0.00184	CcSEcCtD
Pimozide—Syncope—Epirubicin—sarcoma	0.000212	0.00181	CcSEcCtD
Pimozide—Leukopenia—Epirubicin—sarcoma	0.000212	0.00181	CcSEcCtD
Pimozide—Muscle spasms—Doxorubicin—sarcoma	0.00021	0.0018	CcSEcCtD
Pimozide—CYP3A4—liver—sarcoma	0.00021	0.0036	CbGeAlD
Pimozide—Palpitations—Epirubicin—sarcoma	0.000209	0.00179	CcSEcCtD
Pimozide—HRH1—lymph node—sarcoma	0.000209	0.00357	CbGeAlD
Pimozide—Loss of consciousness—Epirubicin—sarcoma	0.000208	0.00178	CcSEcCtD
Pimozide—CYP2D6—liver—sarcoma	0.000207	0.00355	CbGeAlD
Pimozide—Vision blurred—Doxorubicin—sarcoma	0.000206	0.00176	CcSEcCtD
Pimozide—Convulsion—Epirubicin—sarcoma	0.000205	0.00175	CcSEcCtD
Pimozide—Nausea—Etoposide—sarcoma	0.000205	0.00175	CcSEcCtD
Pimozide—Hypertension—Epirubicin—sarcoma	0.000204	0.00174	CcSEcCtD
Pimozide—ABCB1—lymphoid tissue—sarcoma	0.000202	0.00347	CbGeAlD
Pimozide—Anaemia—Doxorubicin—sarcoma	0.000202	0.00173	CcSEcCtD
Pimozide—Myalgia—Epirubicin—sarcoma	0.000201	0.00172	CcSEcCtD
Pimozide—Chest pain—Epirubicin—sarcoma	0.000201	0.00172	CcSEcCtD
Pimozide—Agitation—Doxorubicin—sarcoma	0.000201	0.00172	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.0002	0.00171	CcSEcCtD
Pimozide—Dry mouth—Epirubicin—sarcoma	0.000197	0.00168	CcSEcCtD
Pimozide—Syncope—Doxorubicin—sarcoma	0.000196	0.00168	CcSEcCtD
Pimozide—Leukopenia—Doxorubicin—sarcoma	0.000196	0.00167	CcSEcCtD
Pimozide—Palpitations—Doxorubicin—sarcoma	0.000193	0.00165	CcSEcCtD
Pimozide—Loss of consciousness—Doxorubicin—sarcoma	0.000192	0.00164	CcSEcCtD
Pimozide—Shock—Epirubicin—sarcoma	0.00019	0.00162	CcSEcCtD
Pimozide—Convulsion—Doxorubicin—sarcoma	0.00019	0.00162	CcSEcCtD
Pimozide—Nervous system disorder—Epirubicin—sarcoma	0.000189	0.00162	CcSEcCtD
Pimozide—Hypertension—Doxorubicin—sarcoma	0.000189	0.00161	CcSEcCtD
Pimozide—Tachycardia—Epirubicin—sarcoma	0.000188	0.00161	CcSEcCtD
Pimozide—Skin disorder—Epirubicin—sarcoma	0.000187	0.0016	CcSEcCtD
Pimozide—Hyperhidrosis—Epirubicin—sarcoma	0.000187	0.00159	CcSEcCtD
Pimozide—Chest pain—Doxorubicin—sarcoma	0.000186	0.00159	CcSEcCtD
Pimozide—Myalgia—Doxorubicin—sarcoma	0.000186	0.00159	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000185	0.00158	CcSEcCtD
Pimozide—ABCB1—bone marrow—sarcoma	0.000184	0.00316	CbGeAlD
Pimozide—Anorexia—Epirubicin—sarcoma	0.000184	0.00157	CcSEcCtD
Pimozide—Dry mouth—Doxorubicin—sarcoma	0.000182	0.00156	CcSEcCtD
Pimozide—Hypotension—Epirubicin—sarcoma	0.00018	0.00154	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000176	0.0015	CcSEcCtD
Pimozide—Shock—Doxorubicin—sarcoma	0.000176	0.0015	CcSEcCtD
Pimozide—Nervous system disorder—Doxorubicin—sarcoma	0.000175	0.0015	CcSEcCtD
Pimozide—Insomnia—Epirubicin—sarcoma	0.000175	0.00149	CcSEcCtD
Pimozide—Tachycardia—Doxorubicin—sarcoma	0.000174	0.00149	CcSEcCtD
Pimozide—Skin disorder—Doxorubicin—sarcoma	0.000173	0.00148	CcSEcCtD
Pimozide—Hyperhidrosis—Doxorubicin—sarcoma	0.000173	0.00147	CcSEcCtD
Pimozide—Somnolence—Epirubicin—sarcoma	0.000172	0.00147	CcSEcCtD
Pimozide—Anorexia—Doxorubicin—sarcoma	0.00017	0.00145	CcSEcCtD
Pimozide—Decreased appetite—Epirubicin—sarcoma	0.000168	0.00143	CcSEcCtD
Pimozide—Hypotension—Doxorubicin—sarcoma	0.000167	0.00143	CcSEcCtD
Pimozide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000167	0.00142	CcSEcCtD
Pimozide—Constipation—Epirubicin—sarcoma	0.000165	0.00141	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000163	0.00139	CcSEcCtD
Pimozide—Insomnia—Doxorubicin—sarcoma	0.000162	0.00138	CcSEcCtD
Pimozide—Somnolence—Doxorubicin—sarcoma	0.000159	0.00136	CcSEcCtD
Pimozide—ABCB1—testis—sarcoma	0.000158	0.0027	CbGeAlD
Pimozide—Decreased appetite—Doxorubicin—sarcoma	0.000155	0.00133	CcSEcCtD
Pimozide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000154	0.00132	CcSEcCtD
Pimozide—Urticaria—Epirubicin—sarcoma	0.000153	0.00131	CcSEcCtD
Pimozide—Constipation—Doxorubicin—sarcoma	0.000153	0.0013	CcSEcCtD
Pimozide—ABCB1—liver—sarcoma	0.000149	0.00255	CbGeAlD
Pimozide—Urticaria—Doxorubicin—sarcoma	0.000142	0.00121	CcSEcCtD
Pimozide—Asthenia—Epirubicin—sarcoma	0.000138	0.00118	CcSEcCtD
Pimozide—Pruritus—Epirubicin—sarcoma	0.000137	0.00117	CcSEcCtD
Pimozide—Diarrhoea—Epirubicin—sarcoma	0.000132	0.00113	CcSEcCtD
Pimozide—Asthenia—Doxorubicin—sarcoma	0.000128	0.00109	CcSEcCtD
Pimozide—Dizziness—Epirubicin—sarcoma	0.000128	0.00109	CcSEcCtD
Pimozide—Pruritus—Doxorubicin—sarcoma	0.000126	0.00108	CcSEcCtD
Pimozide—Vomiting—Epirubicin—sarcoma	0.000123	0.00105	CcSEcCtD
Pimozide—Diarrhoea—Doxorubicin—sarcoma	0.000122	0.00104	CcSEcCtD
Pimozide—Rash—Epirubicin—sarcoma	0.000122	0.00104	CcSEcCtD
Pimozide—Dermatitis—Epirubicin—sarcoma	0.000122	0.00104	CcSEcCtD
Pimozide—Headache—Epirubicin—sarcoma	0.000121	0.00103	CcSEcCtD
Pimozide—Dizziness—Doxorubicin—sarcoma	0.000118	0.00101	CcSEcCtD
Pimozide—Nausea—Epirubicin—sarcoma	0.000115	0.000979	CcSEcCtD
Pimozide—ABCB1—lymph node—sarcoma	0.000114	0.00196	CbGeAlD
Pimozide—Vomiting—Doxorubicin—sarcoma	0.000114	0.00097	CcSEcCtD
Pimozide—Rash—Doxorubicin—sarcoma	0.000113	0.000962	CcSEcCtD
Pimozide—Dermatitis—Doxorubicin—sarcoma	0.000112	0.000961	CcSEcCtD
Pimozide—Headache—Doxorubicin—sarcoma	0.000112	0.000956	CcSEcCtD
Pimozide—Nausea—Doxorubicin—sarcoma	0.000106	0.000906	CcSEcCtD
Pimozide—HTR2A—Signaling by GPCR—NRAS—sarcoma	1.35e-05	7.44e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—KIT—sarcoma	1.34e-05	7.42e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—NRAS—sarcoma	1.34e-05	7.42e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—KRAS—sarcoma	1.34e-05	7.41e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL2—sarcoma	1.33e-05	7.35e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—KIT—sarcoma	1.32e-05	7.3e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—NRAS—sarcoma	1.32e-05	7.3e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—HRAS—sarcoma	1.32e-05	7.29e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—MDM2—sarcoma	1.32e-05	7.27e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—MDM2—sarcoma	1.32e-05	7.27e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—SRC—sarcoma	1.31e-05	7.24e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—HRAS—sarcoma	1.31e-05	7.22e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CREB1—sarcoma	1.3e-05	7.19e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—SRC—sarcoma	1.29e-05	7.14e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL2—sarcoma	1.29e-05	7.11e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL2—sarcoma	1.29e-05	7.11e-05	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—HRAS—sarcoma	1.28e-05	7.08e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CREB1—sarcoma	1.28e-05	7.08e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CREB1—sarcoma	1.28e-05	7.06e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—VEGFA—sarcoma	1.28e-05	7.06e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL2—sarcoma	1.27e-05	7.02e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—NRAS—sarcoma	1.26e-05	6.97e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—VEGFA—sarcoma	1.26e-05	6.95e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL2—sarcoma	1.26e-05	6.95e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CREB1—sarcoma	1.26e-05	6.95e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MDM2—sarcoma	1.26e-05	6.94e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—EGFR—sarcoma	1.25e-05	6.88e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—NRAS—sarcoma	1.24e-05	6.87e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—HRAS—sarcoma	1.24e-05	6.85e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—HRAS—sarcoma	1.24e-05	6.85e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CCND1—sarcoma	1.24e-05	6.84e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—JUN—sarcoma	1.24e-05	6.83e-05	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—HRAS—sarcoma	1.23e-05	6.8e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MDM2—sarcoma	1.23e-05	6.78e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CCND1—sarcoma	1.23e-05	6.77e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—EGFR—sarcoma	1.23e-05	6.77e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CTNNB1—sarcoma	1.23e-05	6.77e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—JUN—sarcoma	1.23e-05	6.76e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—EGFR—sarcoma	1.23e-05	6.76e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL2—sarcoma	1.22e-05	6.72e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MDM2—sarcoma	1.22e-05	6.71e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MDM2—sarcoma	1.22e-05	6.71e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CTNNB1—sarcoma	1.22e-05	6.71e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KDR—sarcoma	1.21e-05	6.7e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—EGFR—sarcoma	1.21e-05	6.65e-05	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—HRAS—sarcoma	1.19e-05	6.58e-05	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—HRAS—sarcoma	1.19e-05	6.58e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—JUN—sarcoma	1.18e-05	6.54e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—KRAS—sarcoma	1.18e-05	6.5e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL2—sarcoma	1.18e-05	6.5e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL2—sarcoma	1.18e-05	6.5e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—MYC—sarcoma	1.18e-05	6.49e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—CTNNB1—sarcoma	1.18e-05	6.49e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KDR—sarcoma	1.17e-05	6.48e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KDR—sarcoma	1.17e-05	6.48e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—KRAS—sarcoma	1.16e-05	6.4e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—MYC—sarcoma	1.16e-05	6.4e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—KRAS—sarcoma	1.16e-05	6.39e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PLCG1—sarcoma	1.16e-05	6.37e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—EGFR—sarcoma	1.15e-05	6.35e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—JUN—sarcoma	1.15e-05	6.32e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—JUN—sarcoma	1.15e-05	6.32e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—HRAS—sarcoma	1.14e-05	6.3e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—KRAS—sarcoma	1.14e-05	6.28e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—CTNNB1—sarcoma	1.14e-05	6.27e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—CTNNB1—sarcoma	1.14e-05	6.27e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—EGFR—sarcoma	1.13e-05	6.26e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KIT—sarcoma	1.12e-05	6.17e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—NRAS—sarcoma	1.12e-05	6.17e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—SRC—sarcoma	1.11e-05	6.12e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—SRC—sarcoma	1.1e-05	6.06e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL2—sarcoma	1.1e-05	6.06e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—KRAS—sarcoma	1.09e-05	6e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—CTNNB1—sarcoma	1.09e-05	5.99e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KIT—sarcoma	1.08e-05	5.97e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KIT—sarcoma	1.08e-05	5.97e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—NRAS—sarcoma	1.08e-05	5.97e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—NRAS—sarcoma	1.08e-05	5.97e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—VEGFA—sarcoma	1.08e-05	5.96e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MDM2—sarcoma	1.08e-05	5.95e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—KRAS—sarcoma	1.07e-05	5.91e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—VEGFA—sarcoma	1.07e-05	5.91e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CCND1—sarcoma	1.07e-05	5.9e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—JUN—sarcoma	1.07e-05	5.89e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—NRAS—sarcoma	1.07e-05	5.89e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CREB1—sarcoma	1.06e-05	5.88e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—SRC—sarcoma	1.06e-05	5.86e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MDM2—sarcoma	1.06e-05	5.86e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CTNNB1—sarcoma	1.06e-05	5.85e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MDM2—sarcoma	1.06e-05	5.84e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—NRAS—sarcoma	1.06e-05	5.83e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—CTNNB1—sarcoma	1.05e-05	5.79e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—CTNNB1—sarcoma	1.05e-05	5.79e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MDM2—sarcoma	1.04e-05	5.75e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CREB1—sarcoma	1.03e-05	5.68e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CREB1—sarcoma	1.03e-05	5.68e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—SRC—sarcoma	1.03e-05	5.67e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—SRC—sarcoma	1.03e-05	5.67e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—NRAS—sarcoma	1.02e-05	5.64e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—EGFR—sarcoma	1.02e-05	5.62e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—HRAS—sarcoma	1e-05	5.53e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MYC—sarcoma	9.94e-06	5.49e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—NRAS—sarcoma	9.89e-06	5.46e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—NRAS—sarcoma	9.89e-06	5.46e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—EGFR—sarcoma	9.86e-06	5.44e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—EGFR—sarcoma	9.86e-06	5.44e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—HRAS—sarcoma	9.86e-06	5.44e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MYC—sarcoma	9.85e-06	5.43e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—HRAS—sarcoma	9.84e-06	5.43e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—SRC—sarcoma	9.81e-06	5.41e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—EGFR—sarcoma	9.73e-06	5.37e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—HRAS—sarcoma	9.68e-06	5.34e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TP53—sarcoma	9.66e-06	5.33e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL2—sarcoma	9.64e-06	5.32e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—EGFR—sarcoma	9.63e-06	5.31e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—KRAS—sarcoma	9.63e-06	5.31e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—SRC—sarcoma	9.58e-06	5.28e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TP53—sarcoma	9.52e-06	5.25e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—SRC—sarcoma	9.49e-06	5.24e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—SRC—sarcoma	9.49e-06	5.24e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL2—sarcoma	9.48e-06	5.23e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL2—sarcoma	9.46e-06	5.22e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—NRAS—sarcoma	9.44e-06	5.21e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CCND1—sarcoma	9.4e-06	5.18e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—JUN—sarcoma	9.38e-06	5.17e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—VEGFA—sarcoma	9.33e-06	5.15e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—KRAS—sarcoma	9.31e-06	5.14e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—KRAS—sarcoma	9.31e-06	5.14e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—EGFR—sarcoma	9.31e-06	5.14e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL2—sarcoma	9.31e-06	5.14e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CTNNB1—sarcoma	9.3e-06	5.13e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CCND1—sarcoma	9.25e-06	5.1e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—HRAS—sarcoma	9.24e-06	5.1e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—JUN—sarcoma	9.23e-06	5.09e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CCND1—sarcoma	9.23e-06	5.09e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—NRAS—sarcoma	9.22e-06	5.08e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—JUN—sarcoma	9.21e-06	5.08e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—KRAS—sarcoma	9.19e-06	5.07e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CTNNB1—sarcoma	9.16e-06	5.05e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CTNNB1—sarcoma	9.14e-06	5.04e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—NRAS—sarcoma	9.13e-06	5.04e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—NRAS—sarcoma	9.13e-06	5.04e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—HRAS—sarcoma	9.11e-06	5.02e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—KRAS—sarcoma	9.1e-06	5.02e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CCND1—sarcoma	9.08e-06	5.01e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—JUN—sarcoma	9.06e-06	5e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—EGFR—sarcoma	9.01e-06	4.97e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—EGFR—sarcoma	9.01e-06	4.97e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CTNNB1—sarcoma	8.99e-06	4.96e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MDM2—sarcoma	8.81e-06	4.86e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—KRAS—sarcoma	8.8e-06	4.85e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MYC—sarcoma	8.79e-06	4.85e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—EGFR—sarcoma	8.6e-06	4.74e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MYC—sarcoma	8.58e-06	4.74e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MDM2—sarcoma	8.52e-06	4.7e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MDM2—sarcoma	8.52e-06	4.7e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—KRAS—sarcoma	8.51e-06	4.7e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—KRAS—sarcoma	8.51e-06	4.7e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MYC—sarcoma	8.5e-06	4.69e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MYC—sarcoma	8.5e-06	4.69e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—SRC—sarcoma	8.41e-06	4.64e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EGFR—sarcoma	8.4e-06	4.63e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—EGFR—sarcoma	8.32e-06	4.59e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—EGFR—sarcoma	8.32e-06	4.59e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—SRC—sarcoma	8.28e-06	4.57e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—SRC—sarcoma	8.26e-06	4.56e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—sarcoma	8.19e-06	4.52e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—HRAS—sarcoma	8.18e-06	4.52e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—sarcoma	8.17e-06	4.51e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—SRC—sarcoma	8.13e-06	4.48e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—KRAS—sarcoma	8.12e-06	4.48e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—NRAS—sarcoma	8.09e-06	4.46e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—sarcoma	8.09e-06	4.46e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—sarcoma	8.06e-06	4.45e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—sarcoma	8.04e-06	4.44e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—NRAS—sarcoma	7.96e-06	4.39e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—NRAS—sarcoma	7.94e-06	4.38e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—KRAS—sarcoma	7.93e-06	4.38e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—HRAS—sarcoma	7.92e-06	4.37e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—HRAS—sarcoma	7.92e-06	4.37e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—sarcoma	7.91e-06	4.37e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2—sarcoma	7.87e-06	4.34e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—KRAS—sarcoma	7.86e-06	4.33e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—KRAS—sarcoma	7.86e-06	4.33e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NRAS—sarcoma	7.82e-06	4.31e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—HRAS—sarcoma	7.81e-06	4.31e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—HRAS—sarcoma	7.74e-06	4.27e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCND1—sarcoma	7.67e-06	4.23e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—JUN—sarcoma	7.66e-06	4.23e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2—sarcoma	7.62e-06	4.2e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2—sarcoma	7.62e-06	4.2e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CTNNB1—sarcoma	7.6e-06	4.19e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MYC—sarcoma	7.54e-06	4.16e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—HRAS—sarcoma	7.48e-06	4.13e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCND1—sarcoma	7.42e-06	4.1e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCND1—sarcoma	7.42e-06	4.1e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MYC—sarcoma	7.42e-06	4.09e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—JUN—sarcoma	7.41e-06	4.09e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—JUN—sarcoma	7.41e-06	4.09e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MYC—sarcoma	7.4e-06	4.08e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EGFR—sarcoma	7.37e-06	4.07e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CTNNB1—sarcoma	7.35e-06	4.06e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CTNNB1—sarcoma	7.35e-06	4.06e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MYC—sarcoma	7.28e-06	4.02e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EGFR—sarcoma	7.25e-06	4e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EGFR—sarcoma	7.24e-06	3.99e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—HRAS—sarcoma	7.23e-06	3.99e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—HRAS—sarcoma	7.23e-06	3.99e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EGFR—sarcoma	7.12e-06	3.93e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—sarcoma	7.05e-06	3.89e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—KRAS—sarcoma	6.96e-06	3.84e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—HRAS—sarcoma	6.9e-06	3.81e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SRC—sarcoma	6.87e-06	3.79e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—KRAS—sarcoma	6.85e-06	3.78e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—KRAS—sarcoma	6.84e-06	3.77e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—HRAS—sarcoma	6.74e-06	3.72e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—KRAS—sarcoma	6.73e-06	3.71e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—sarcoma	6.69e-06	3.69e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—HRAS—sarcoma	6.68e-06	3.68e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—HRAS—sarcoma	6.68e-06	3.68e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SRC—sarcoma	6.65e-06	3.67e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SRC—sarcoma	6.65e-06	3.67e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NRAS—sarcoma	6.61e-06	3.65e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—sarcoma	6.47e-06	3.57e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—sarcoma	6.47e-06	3.57e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NRAS—sarcoma	6.39e-06	3.53e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NRAS—sarcoma	6.39e-06	3.53e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—sarcoma	6.19e-06	3.41e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MYC—sarcoma	6.16e-06	3.4e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—sarcoma	6.09e-06	3.36e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—sarcoma	6.08e-06	3.35e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EGFR—sarcoma	6.02e-06	3.32e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—sarcoma	5.98e-06	3.3e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MYC—sarcoma	5.95e-06	3.29e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MYC—sarcoma	5.95e-06	3.29e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—HRAS—sarcoma	5.92e-06	3.27e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EGFR—sarcoma	5.82e-06	3.21e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EGFR—sarcoma	5.82e-06	3.21e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—HRAS—sarcoma	5.82e-06	3.21e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—HRAS—sarcoma	5.81e-06	3.21e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—HRAS—sarcoma	5.72e-06	3.16e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KRAS—sarcoma	5.69e-06	3.14e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KRAS—sarcoma	5.5e-06	3.04e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KRAS—sarcoma	5.5e-06	3.04e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—sarcoma	5.06e-06	2.79e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—sarcoma	4.89e-06	2.7e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—sarcoma	4.89e-06	2.7e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HRAS—sarcoma	4.83e-06	2.67e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HRAS—sarcoma	4.68e-06	2.58e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HRAS—sarcoma	4.68e-06	2.58e-05	CbGpPWpGaD
